Males |
Those regularly taking 5α-reductase inhibitors or testosterone replacement medicines |
Aged 18–80 years |
Those on warfarin treatment |
BMI between 19.5–35 kg/m2
|
Those diagnosed with diabetes |
Smokers and non-smokers |
Those diagnosed with or suspected to be high-risk for human immunodeficiency virus (HIV) and/or viral hepatitis |
Scheduled for TPB as part of routine investigation or staging of prostate cancer |
Those allergic to any of the ingredients included in the supplements |
|
Those taking additional dietary supplements or herbal remedies that could affect the study outcome |
|
Those that are unable to understand English or give informed consent |
|
Parallel participation in another research project that involves dietary intervention |
|
Any person related to or living with any member of the study team |